Insight Molecular Diagnostics (IMDX) Intangibles (2015 - 2025)

Insight Molecular Diagnostics has disclosed Intangibles across 10 years of filings, most recently posting $15.0 million for Q3 2025.

• Intangibles for Q3 2025 came in at $15.0 million, up 3318.18% year-over-year; the trailing twelve-month figure through Sep 2025 was $15.0 million (up 3318.18% YoY), and the FY2024 annual result was $15.0 million, down 73.59% from the prior year.
• Intangibles came in at $15.0 million for Q3 2025 at Insight Molecular Diagnostics, up from $14.6 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $94.7 million in Q1 2022 to a low of $440000.0 in Q2 2024.
• The 5-year median for Intangibles is $56.6 million (2024), against an average of $42.5 million.
• Across the five-year window, Intangibles tumbled 99.22% in 2024 and surged 3318.18% in 2025, its largest moves.
• Insight Molecular Diagnostics' Intangibles stood at $61.7 million in 2021, then retreated by 0.14% to $61.6 million in 2022, then dropped by 7.61% to $56.9 million in 2023, then plunged by 73.59% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025.
• The last three Intangibles figures came in at $15.0 million (Q3 2025), $14.6 million (Q2 2025), and $440000.0 (Q1 2025), per Business Quant data.